Publications

    1. Singh A, Singh S, Mani KR, Das KJM, Kumar S. Comparing setup errors using portal imaging in patients with gynecologic cancers by two methods of alignment. Journal of Medical Imaging and Radiation Sciences 2020

    2. S Mishra, F Ahmad , S Singh, R K Singh, K J Maria Das , S Kumar Assessing failure patterns of radical intent radiation strategies in patients with locally advanced carcinoma of the esophagus Cancer Rep (Hoboken) 2020 Dec 28;e1332. doi: 10.1002/cnr2.1332. Online ahead of print.

    3. A Sardaro, F McDonald, L Bardoscia, K Lavrenkov, S Singh, S Ashley, D Traish, C Ferrari, I Meattini, AN Asabella, M Brada. Dyspnea in patients receiving radical radiotherapy for non-small cell lung cancer: A Prospective Study. Front Oncol. 2020.

    4. Jha CJ, Mishra A, Yadav SB, Agarwal G, Singh S, Chand G, Agarwal A.Thyroid dysfunctions and autoimmunity in breast cancer patients: a prospective case-control study. Archives of Endocrinology and Metabolism 2020

    5. Singh A, Singh S, Agrawal S, Verma J , Singh S, Misra P, Jaiswal AK , Behari S , Jaiswal S. A single-centre observational study of 124 surgically managed glioma patients: molecular subtyping and its correlation with clinico-radiological profile. IntSurg J. 2020.

    6. F Ahmad, S Misra, S Pant, S Singh, R .K Singh, K J Das, S Kumar. Patterns of failure following neoadjuvant and definitive radiation strategies in carcinoma thoracic esophagus: Do we need to rethink targets? (abs.) Annals of Oncology 31, S186-S186

    7. S Pant, Y Kumar, S Misra, S Singh, R K Singh, S Kumar Intensifying peri-operative chemotherapy with radiotherapy in resectable gastro-esophageal junction (GEJ) and stomach cancer patients: Initial results of a prospective trial at a tertiary cancer care centre. (abs.) Annals of Oncology 31:S165 July 2020

    8. Kumari N, Singh S Haloi D, Mishra K S, Krishnani N, Nath A, Neyaz Z. Epidermal growth factor response mutation frequency in squamous cell carcinoma and its diagnostic performance in cytological samples : a molecular and immunohistochemical study. World J Oncol 2019

    9. Sastri S, Mathews AS, Maheswari A, Bhatia N, Singh S, Rai Bhawana, TS Shylashree, Ghosh J et al National Cancer Grid of India consensus guidelines on management of cervical cancer. J of Global Oncology 2018.

    10. Singh K A, Srivastava K A, Pal L, Sardhara J, Yadav R, Singh S et al Extraosseous primary intracranial ewing sarcoma/peripheral primitive neuroectodermal tumor: series of seven cases and review of literature. Asian Journal of Neurosurgery 2018.

    11. Misra S, Lal P, EP Saibish, Rastogi N, Tiwari A, Singh S, Das KJM, Kumar S. Comparative assessment of late toxicity in patients of carcinoma cervix treated by radiotherapy versus chemo-radiotherapy – Minimum 5 years follow up. Cancer treatment and Research communications 2018.

    12. Datta NR, Stutz E, Liu M, Rogers S, Klingbiel D, Siebenhüner A, Singh S, Bodis S. To what extent does concurrent chemoradiotherapy influence therapeutic outcome in locally advanced cervix cancer? A systematic review and meta-analysis of 14 randomized trials. GynecolOncol 2017.

    13. Gupta PK, Awasthi R, Singh S, Behari S, Maria Das KJ, Gupta RK, Kumar S. Value of Minimum Apparent Diffusion Coefficient on Magnetic Resonance Imaging as a Biomarker for Predicting Progression of Disease Following Surgery and Radiotherapy in Glial Tumors from a Tertiary Care Center in Northern India. J Neurosci Rural Pract 2017.

    14. Srivastava S, Singh S, Fatima N, Mittal B, Srivastava AN. Pre-microRNA Gene Polymorphisms and Risk of Cervical Squamous Cell Carcinoma.J Clin Diagn Res. 2017 Sep;11(9):GC01-GC04.

    15. Gupta PK, Kumar P, Lal P, Barai S, Prasad N, Jain S, Singh S, Gambhir S, Kumar S. Estimation of prevalence of pretreatment renal insufficiency and use of mathematical formulation to assess the renal dysfunction in patients of head and neck cancers undergoing concurrent chemoradiotherapy in Northern India. Clinical Cancer Investigational Journal 2016

    16. Datta NR, Singh S, Kumar P, Gupta D. Human papillomavirus confers radiosensitivity, in cancer cervix: a hypothesis toward a possible restoration of apoptotic pathways based on clinical outcomes. Future Oncology 2015

    17. Singh S, Singh A, Kumar P, Kumar P. Concurrent chemoradiation therapy confer better survival outcomes in patients with low baseline HPV titres. Int. J. of Gynecol. Cancer 2014

    18. Kumar S, Lal P, Das KJM, Rastogi, N, Agarwal S, Singh S, Kumar SKS, Sait AA, Gupta PK, Verma M, Yadav R, Chaudhari T, Narang K. A process audit of intensity modulated radiotherapy in an academic tertiary care hospital.Indian Journal of Cancer 2013

    19. Singh S, Verma M, Yadav R, Kumar Senthil SK, Maurya AK, Kumar S. Feasibility study of intensity modulated radiotherapy in cancer cervix with inadequate surgical staging : Analysis of loco-regional control & toxicities.Int. J. of Gyneco.l Cancer 2013

    20. Gupta PK, Singh S, Lal P, Rastogi N, Kumar S. Community based practices for endometrial cancer referred for adjuvant treatment to a tertiary care hospital in northern India- 10 years audit.European Journal of Cancer 2013

    21. Singh S, Kumar S Maurya AK. Influence of bladder distension on organ at risk wall doses in intracavitary brachytherapy of cervical cancer. Radiotherapy Oncology 2013

    22. Chopra S, Engineer R, Mahantshetty U, Misra S, Phurailatpam R, Paul SN, Kannan S, Kerkar R, Maheshwari A, ShylasreeTs, Ghosh J, Gupta S, Thomas B, Singh S, Sharma S, Chilikuri S, Shrivastava SK.Protocol for a phase III randomised trial of image-guided intensity modulated radiotherapy (IG-IMRT and conventional radiotherapy for late small bowel toxicity reduction after postoperative adjuvant radiation in Ca cervix. BMJ Open 2012

    23. Singh S, Singh A, Maria Das KJM, Singh H, Kumar S. Setup errors using portal imaging in patients with gynecological cancer by two methods of alignment. Radiotherapy Oncology 2011

    24. Pandey S, Mittal B, Srivastava M, Singh S, Srivastava K, Mittal RD. Evaluation of Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in cervical cancer susceptibility.MolBiol Rep 2010

    25. Lavrenkov K, Singh S, Christian JA, Partridge M, Nioutsikou E, Cook G, Bedford JL, Brada M. Effective avoidance of a functional SPECT-perfused lung using intensity modulated radiotherapy (IMRT) for non-small cell lung cancer (NSCLC): An update of a planning study.Radiotherapy Oncology 2009

    26. Pandey S, Mittal RD, Srivastava M, Srivastava K, Singh S, Srivastava S, Mittal B.Impact of Toll-like receptors [TLR] 2 (-196 to -174 del) and TLR 4 (Asp299Gly, Thr399Ile) in cervical cancer susceptibility in North Indian women.GynecolOncol 2009

    27. Datta NR, Kumar P, Singh S, Gupta D, Srivastava A, Dhole TN. Does pretreatment human papillomavirus (HPV) titers predict radiation response and survival outcomes in cancer cervix? - A pilot study.GynecolOncol 2009

    28. Singh S, Datta NR, Krishnani N, Lal P, Kumar S. Radiation therapy induced micronuclei in cervical cancer – does it have a predictive value for local disease control? GynecolOncol 2009

    29. Kumar P, Singh S, Datta NR, Tandon A. Epitrochlear lymph node metastasis from invasive ductal cancer. J Cancer Res Ther 2009

    30. Khurana R, Singh S. Isolated cutaneous metastasis to thigh from cancer cervix- fourteen years after curative radiotherapy. The Int Journal of Gynecology and Obstretics, 2009

    31. Kumar P, Kumar P, Singh S, Kumari N, Datta NR. Chordoma with increased prolactin levels (pseudoprolactinoma) mimicking pituitary adenoma: A case report with review of literature. J Cancer Res Ther. 2009

    32. Kumar P, Singh S, Kumar P, Krishnani N, Datta NR. Gliosarcoma: an audit of single institution in India of post-irradiated cases over 15 years. J Cancer Res Ther. 2008

    33. Lal P, Pal L, Kumar S, Dimri K, Tiwari A, Rastogi N, Singh S, Datta NR. Implications of p53 over-expression in the outcome with radiation in head and neck cancers.J Cancer Res Ther. 2007

    34. Kumar P, Singh S, Phadke R V, Diwakar H, Agarawal T, Jain M, Datta NR. Role of radiotherapy in a recurrent aneurysmal bone cyst of the temporal bone- case report. Neurosurgery 2006

    35. Kumar P, Agarwal T, Krishnani N, Singh S,Datta NR. Role of adjuvant radiotherapy in metaplastic matrix producing breast cancer: A case study with review of literature. J Cancer Res Ther. 2006

    36. Singh S, Datta NR, Krishnani N, Lal P, Kumar S. Radiation therapy induced micronuclei in cervical cancer - does it have a predictive value for local disease control?Gynecologic Oncology 2005

    37. Srivastava K, Singh S, Srivastava M. Incisional skin metastasis of a squamous cell cervical carcinoma 3.5years after radical treatment- a case report. Int. J of Gynecological Cancer 2005

    38. Nagar YS, Singh S, Sawlani V, Pal L, Dimri K, Lal P. Primary papillary serous cystadenocarcinoma of broad ligament.AustralasRadiol. 2005

    39. Nagar YS, Singh S, Datta NR. Chemo-irradiation in persistent / recurrent head and neck cancers.Jap J ClinOncol 2004

    40. Datta NR, Nagar YS, Singh S, Narayan L. Loco-regional failures in head and neck cancers: Can they be effectively salvaged by nonsurgical therapeutic modalities? Int J ClinOncol 2003

    41. Lal P, Nagar YS, Kumar S, Singh S, Das KJM., SL Narayan, Kumar R, Jain VK, Ayyagari S. Medulloblastomas: Clinical profile, treatment techniques and outcome - An Institutional experience. Ind J Cancer 2002

    42. Singh S, Lal P, Sikora SS, Datta NR. Squamous cell carcinoma arising from a congenital duplication cyst of the esophagus in a young adult.Dis Esophagus 2001

    Research as investigator / co-investigator from various sources

    1. Hospital Based Cancer Registry under the National Cancer Registry Program (NCRP) cancer head neck, cancer cervix and cancer breast ICMR, New Delhi (Extramural)

    2. Role of serum biomarkers in high grade gliomas SGPGIMS, Lucknow (Intramural)

    3. Circulating microRNA as a potential diagnostic marker in lung cancer SGPGIMS, Lucknow (Intramural)

    4. Prevalence of EGFR mutation and response to tyrosine kinase inhibitor in advanced non-small cell lung cancer in north Indian population SGPGIMS, Lucknow (Intramural)

    5. Planning optimization for target volume coverage and organs at risk doses in intracavitary brachytherapy for cervical cancer based on 3DCT data SGPGIMS, Lucknow (Intramural)

    6. Prevalence of Thyroid Dysfunctions in Breast Cancer Patients and Correlation with Clinico-pathologic Factors and Outcome of Therapy: A Prospective Case Control study SGPGIMS, Lucknow (Intramural)

    7. Utility and predictive value of diffusion weighted MR imaging in patients with cancer cervix undergoing radiation therapy SGPGIMS, Lucknow (Intramural)